Washington, D.C. (June 25, 2025) – The RWE Alliance is pleased to announce the addition of Datavant, a leading health data platform company, which joins other leading real-world data and analytics organizations as a new member of the RWE Alliance.
The RWE Alliance is a policy and advocacy coalition of real-world data (RWD) and analytics organizations with a common interest in harnessing the power of real-world evidence to inform regulatory decision making to improve the lives of patients. The RWE Alliance regularly contributes a valued, expert voice on RWE policymaking on key issues affecting the use of real-world evidence, including data standards and artificial intelligence, with Congress, the U.S. Food and Drug Administration (FDA), and other offices and agencies within the Health and Human Services (HHS).
“There are clear opportunities to make real-world data more usable and impactful in regulatory decision making,” said Arnaub Chatterjee, President and GM of Life Sciences, Ecosystem, and Public Sector at Datavant. “We’re excited to join the RWE Alliance and collaborate with industry leaders to accelerate innovation and shape the future of decision-grade real-world evidence.”
The RWE Alliance’s members are thrilled to welcome Datavant to the coalition and look forward to joining together to advance the use of RWE to support regulatory decisions and benefit patients.
About RWE Alliance
We are a coalition of real-world data and analytics organizations with a common interest in harnessing the power of real-world evidence to inform regulatory decision making to improve the lives of patients.
For Media Inquiries:
info@rwealliance.org